Popular terms

[SEARCH]

Dimethyl topics
Physiologic
Hydrochloric Acid
Fresnel Zone
Aberration
Ophthalmic
Liquid Crystal
Imaging System
Pharmaceutically Acceptable Salt
Pharmaceutically Acceptable Salts
Chloric Acid
Tartaric Acid
Fumaric Acid
Antagonist
Bradykinin
Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Dimethyl patents



      
           
This page is updated frequently with new Dimethyl-related patent applications. Subscribe to the Dimethyl RSS feed to automatically get the update: related Dimethyl RSS feeds. RSS updates for this page: Dimethyl RSS RSS


Process for production of dme from crude methanol

Haldor Topsøe A/s

Process for production of dme from crude methanol


Date/App# patent app List of recent Dimethyl-related patents
08/27/15
20150243441 
 Method for forming pattern patent thumbnailnew patent Method for forming pattern
The invention provides a process and an apparatus for producing a high quality electronic component by reducing sagging at pattern side walls, which may occur when patterns of a wiring, an electrode, etc. Are printed by a screen printing process using an electroconductive paste, an insulation paste, or a semiconductor paste, and reducing a mesh mark on the patterns of a wiring, an electrode, etc., or a full solid surface film, as well as a pattern formation process, by which screen printing can be applied and double face printing can be conducted with the number of process steps less than a conventional process.
National Institute Of Advanced Industrial Science And Technology


08/27/15
20150243404 
 Polydimethylsiloxane (pdms) based composite and synthesis method thereof patent thumbnailnew patent Polydimethylsiloxane (pdms) based composite and synthesis method thereof
A pdms-based composite and a synthesis method thereof are disclosed. The pdms-based composite comprises a pdms gel and a plurality of conducting particles distributed within the pdms gel.
Nano And Advanced Materials Institute Limited


08/27/15
20150240386 
 Pile fabric and  manufacturing the same patent thumbnailnew patent Pile fabric and manufacturing the same
The present invention relates to a pile fabric including an acrylic synthetic fiber at a napped portion, the acrylic synthetic fiber is obtained by spinning a spinning solution including 90 to 99 parts by weight of a polymer a and 1 to 10 parts by weight of a polymer b. The polymer a is a polymer obtained by polymerizing a composition a including 40 to 97 wt % of acrylonitrile, 0 to 5 wt % of a sulfonic acid-containing monomer and 3 to 60 wt % of another copolymerizable monomer.
Kaneka Corporation


08/27/15
20150240125 
 Repellent coating composition and coating,  making and uses thereof patent thumbnailnew patent Repellent coating composition and coating, making and uses thereof
(ii.d) the polydimethylsiloxane moiety has a molecular weight of more than 1600 g/mol.. .

08/27/15
20150240029 
 Polyester patent thumbnailnew patent Polyester
The present invention relates to polyester that can be obtained by polymerization of a) terephtalacid dimethylester, and b) ethylene glycol, and c) 1,2-propylene glycol, and d) one or a plurality of polyethylene glycols having weight average molecular weights in the range of 1,000 to 2,000 g/mol, and e) one methyl polyethylene glycol having a weight average molecular weight in the range of 1,050 to 1,350 g/mol, f) either when a plurality of compounds having a reticulating effect and 3 to 6 functions that are enabled for polycondensation are present or absent. The polyester according to the invention can be used in an advantageous manner, e.g.
Clariant Finance (bvi) Limited


08/27/15
20150239909 
 Process for the preparation of (1s,4s,5s)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one patent thumbnailnew patent Process for the preparation of (1s,4s,5s)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one
Which is a key intermediate in the synthesis of edoxaban, a compound that exhibits on inhibitory effect on activated blood coagulation factor x (also referred to as activated factor x or fxa), and is useful as a preventive and/or therapeutic drug for thrombotic diseases. The process includes reacting (1s)-cyclohex-3-ene-1-carboxylic acid of formula (ii) with a brominating agent selected from the group consisting of n-bromosuccinimide or 1,3-dibromo-5, 5-dimethylhydantoin in the presence of a base selected from calcium oxide or calcium hydroxide in a solvent selected from the group comprising of dicholoromethane, toluene, tetrahydrofuran, ethyl acetate, hexanes, cyclopentyl methyl ether (cpme) or a misture thereof to get (1s, 4s 5s)-4-bromo-6-oxabicyclo[3.2.1]octan-y-one of formula (1).

08/27/15
20150239816 
 Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal with chloroacetone patent thumbnailnew patent Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal with chloroacetone
The invention discloses a method for the preparation of 2-(2,3-dimethylphenyl)-1-propanal starting from 1-bromo 2,3-dimethylbenzene and chloroacetone, its use in perfumes and its use for the preparation of medetomidine.. .
Lonza Ltd


08/27/15
20150239813 
 Process for production of dme from crude methanol patent thumbnailnew patent Process for production of dme from crude methanol
The invention provides a process for the production of purified dimethylether (dme). Methanol is dehydrated to provide a first dme-containing product.
Haldor Topsøe A/s


08/27/15
20150238523 
 Method of production of the stable selenium-comprising pharmaceutical composition with a high selenium level patent thumbnailnew patent Method of production of the stable selenium-comprising pharmaceutical composition with a high selenium level
The present disclosure relates to the new method of producing of the stable selenium-comprising pharmaceutical compositions with a high selenium level based on the mixing of nitric acid with therapeutically effective amounts of at least two active ingredients selected from the groups consisting of 2,2-dichlorocarboxylic acids, selenium-containing compound. As a selenium-containing compound the aqueous solution of selenious acid in the amount of no more than 20%, preferably 0.5-10.0%, is used.
Obschestvos S. Ogranitchennoi Otvetstvennostju "oxygon"


08/27/15
20150238472 
 Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof patent thumbnailnew patent Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof
The present disclosure provides ddah modulators. Thus, the present disclosure provides a method of treating a patient suffering from a disorder characterized by excessive no production and/or elevated ddah activity, the method comprising administering to said patient an effective amount of a compound of one of formulae i-x.
The Board Of Trustees Of The Leland Stanford Junior University


08/27/15
20150238408 
new patent

Ester gels, methods of manufacture, and uses thereof


Gels of isopropyl esters of fatty alcohols that include a dimethyl/methylhydrogensiloxane copolymer, a silanol-terminated pdms or an ethenyl-terminated pdms, and a hydride functional siloxane. Also provided are methods for making the gels and articles containing them..
Jeen International Corporation


08/20/15
20150232608 

Polyurethane casting compound for producing wear protection coatings in casting house applications


The present invention relates to multi-component compositions including an isocyanate component and an amine component, wherein the isocyanate component includes a prepolymer, obtainable from toluene isocyanate and a polytetramethylene polyol, and the amine component includes a dialkylthio aryl diamine and possibly a polytetramethylene oxide polyamine. Corresponding compositions can be advantageously used as flowable or spreadable resin systems for producing surface protection coatings in casting house applications and are characterized by a significantly improved resistance to abrasion in comparison with conventional casting resin systems based on hexamethylene diisocyanate and dimethyl thiotoluene diamine..
Sika Technology Ag


08/20/15
20150232402 

Method for producing dimethyl ether and device suitable therefor


The present disclosure relates to a method and apparatus for producing dimethyl ether by catalytic dehydration of methanol and by distillation of the dehydration product. The method is characterized in that the catalytic dehydration takes place in at least two reaction stages which are connected in series and of which at least the first reaction stage is operated adiabatically, wherein a cooling of the reaction products takes place at least between the first and the second reaction stages..
Thyssenkrupp Industrial Solutions Ag


08/20/15
20150232401 

Process for the preparation of dimethyl ether


Process for the preparation of dimethyl ether product by catalytic conversion of synthesis gas to dimethyl ether comprising the steps of contacting a stream of synthesis gas comprising carbon dioxide in a dimethyl ether synthesis step in one or more reactors and with one or more catalysts active in the formation of methanol and dehydration of methanol to dimethyl ether and forming a product mixture comprising dimethyl ether, carbon dioxide and unconverted synthesis gas; cooling and separating the product mixture into a first liquid phase comprising dimethyl ether and carbon dioxide being dissolved in the formed dimethyl ether, and into a first gaseous phase comprising unconverted synthesis gas containing carbon monoxide and carbon dioxide; passing the first liquid phase to a scrubbing zone and contacting the phase with a liquid sorbent being effective in absorption of carbon dioxide; and withdrawing a dimethyl ether product being depleted in carbon dioxide from the scrubbing zone.. .
Haldor Topsoe A/s


08/20/15
20150231270 

Multivalent pneumococcal polysaccharide-protein conjugate composition


An immunogenic composition having 13 distinct polysaccharide-protein conjugates and optionally, an aluminum-based adjuvant, is described. Each conjugate contains a capsular polysaccharide prepared from a different serotype of streptococcus pneumoniae (1, 3, 4, 5, 6a, 6b, 7f, 9v, 14, 18c, 19a, 19f and 23f) conjugated to a carrier protein.
Wyeth Llc


08/20/15
20150231107 

Organoarsenic compounds and methods for the treatment of cancer


A method for treating a lymphoma selected from non-hodgkin's and hodgkin's lymphoma comprising administering an organoarsenic compound having a structure of the formula (i) wherein x is s or se and r1 and r2 are independently c1-30alkyl (r3, r3′, r4, r5, w and “n” are as defined in claim 1) in particular where the compound is s-dimethylarsinoglutathione, n-(2-s-dimethylarsinothiopropionyl)glycine, 2-amino-3-(dimethylarsino)thio-3-methylbutanoic acid, s-dimethylarsino-thiosuccinic acid or s-dipropylarsino-1-thioglycerol.. .

08/13/15
20150225386 

Chromane compounds


The present invention provides a hydrate of n-[(4s)-2-amino-2′,2′-dimethyldispiro[1,3-oxazole-4,4′-chromene-3′,3″-oxetan]-6′-yl]-5-chloropyridine-2-carboxamide which is useful as an active ingredient of a pharmaceutical composition, in particular, a pharmaceutical composition for preventing or treating diseases or conditions associated with and/or mediated by β-secretase activity, hydrolysis of a β-secretase site of a β-amyloid precursor protein, and/or β-amyloid protein accumulation, including a pharmaceutical composition for preventing or treating diseases including, but not limited to, glaucoma, mci (mild cognitive impairment) or alzheimer's disease, especially, alzheimer's disease.. .
Comentis, Inc.


08/06/15
20150221983 

Lithium secondary battery and producing same


This invention provides a lithium secondary battery comprising a positive electrode, a negative electrode, and a non-aqueous electrolyte. On the negative electrode surface, there is present a cyclic siloxane and/or a reaction product thereof.
Toyota Jidosha Kabushiki Kaisha


08/06/15
20150218491 

Use of polyesters in washing and cleaning agents


The present invention relates to the use in washing and cleaning agents of one or a plurality of polyesters which can be obtained by polymerisation of a) terephthalic acid dimethyl ester, and b) ethylene glycol, and c) 1,2-propylene glycol, and d) one or a plurality of polyethylene glycols with mass-average molecular weights in the range from 1000 to 2000 g/mol, and e) a methyl polyethylene glycol with a mass-average molecular weight in the range from 1050 to 1350 g/mol, f) either in the presence of or in the absence of one or a plurality of cross-linking compounds with 3 to 6 polycondensation-capable functions. The polyesters are particularly suited for use in the washing and cleaning agents as dispersants or as soil release polymers..
Clariant Finance (bvi) Limited


08/06/15
20150218467 

Strong base amines to minimize corrosion in systems prone to form corrosive salts


Corrosion by ammonia/amine salts in hydrocarbon streams such as distillation overhead streams that contain a mineral acid and water can be prevented, avoided or minimized by adding certain strong amines to the streams. The amines have a pka between about 10.5 to about 12 and include, but are not necessarily limited to, dimethylamine, diethylamine, dipropylamine, diisopropylamine, di-n-butylamine, diisobutylamine, di-sec-butylamine, di-tert-butylamine, pyrrolidine, piperidine, and combinations thereof.
Baker Hughes Incorporated


08/06/15
20150218107 

Aggrecanase inhibitors


The present invention provides compounds having the formula: wherein r1 is selected from methyl, ethyl, propyl, cyclopropyl, and dimethyl, or a pharmaceutically acceptable salt thereof, along with methods and intermediates for their preparation, and uses thereof.. .
Eli Lily And Company


08/06/15
20150218105 

Method for producing 1-substituted-3-fluoroalkylpyrazole-4-carboxylic acid ester


The present invention is a method for producing a 1-substituted-3-fluoroalkylpyrazole-4-caroxylic acid ester, the method comprising a step of adding, to a first reaction liquid containing an alkyl hydrazine and a first organic solvent, a second reaction liquid containing an acyl acetic acid ester derivative and a second organic solvent in 0.5 to 30 hours to react the first reaction liquid with the second reaction liquid at a reaction temperature of −5 to 80° c. Under stirring in the absence of a base and an acid, wherein the first organic solvent and the second organic solvent are each at least any one of benzene, toluene, xylene, chlorobenzene, dichlorobenzene, ethyl acetate, butyl acetate, and dimethyl carbonate, a total mass of the first organic solvent and the second organic solvent is 1 to 60 times a mass of the acyl acetic acid ester derivative, and an amount of the first organic solvent in a total amount of the first organic solvent and the second organic solvent is 40 to 95% by mass..
Tama Kagaku Kogyo Co., Ltd


08/06/15
20150216977 

Stable pharmaceutical composition, comprising an aqueous solution of an antibody-derived therapeutically active protein


A storage-stable pharmaceutical composition includes an aqueous solution of at least an antibody-derived therapeutically active protein chosen amongst antibody, nanobody or fusion protein and an amount effective to stabilize the antibody-derived therapeutically active protein of at least one lauryldimethylamineoxide and/or of one of its amine oxide analogs.. .
Adocia


08/06/15
20150216821 

Abuse-proofed oral dosage form


The present invention relates to an abuse-proofed oral dosage form with controlled release of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol for once daily administration, which comprises the active ingredient and/or one or more of the pharmaceutically acceptable salts thereof (a), at least one synthetic or natural polymer (c), delayed-release auxiliary substances, optionally physiologically acceptable auxiliary substances (b) and optionally a wax (d), component (c) or (d) in each case exhibiting a breaking strength of at least 500 n, preferably of at least 1000 n.. .
GrÜnenthal Gmbh


08/06/15
20150216789 

Hair care polymer


The invention relates to specific quaternized hyperbranched polymers having end-groups of formula (i) characterized in that said quaternized hyperbranched polymer is obtainable by preparation of a hyperbranched polymer having dimethylamino end groups by condensation of 2-dodecen-1-ylsuccinic anhydride, diisopropanolamine and n,n-bis[3-(dimethylamino)propyl]amine followed by quaternization of the dimethylamino end-groups to end groups of formula (i). Furthermore, the invention is directed to clear shampoo preparations comprising such quaternized hyperbranched polymers..
Dsm Ip Assets B.v.


08/06/15
20150216476 

Strain sensor device with a biological substrate and manufacturing thereof


A strain sensor device having a biological substrate composed of a standalone bone graft or an isolated piece of bone that can be incorporated directly into, or attached to another piece of bone that is then implantable, in a biological subject, and a method thereof. The strain sensor device can includes a strain sensing circuit, which is composed of at least a first dielectric layer and a first conductive layer, that functions as a strain gauge.
Innovative In Vivo Sensing, Llc


08/06/15
20150216170 

Synergistic microbicidal combinations


Antimicrobial compositions based on the synergistic combination of 2-methyl-3-isothiazolone and selected commercial microbicides where the compositions are substantially free of halogenated 3-isothiazolone, are disclosed. Particularly preferred are combinations of 2-methyl-3-isothiazolone together with benzoic acid, citric acid, sorbic acid, 1,2-dibromo-2,4-dicyanobutane, 1,3-dimethylol-5,5-dimethylhydantoin, phenoxyethanol, benzyl alcohol, zinc pyrithione or climbazole, that provide enhanced microbicidal efficacy at a combined active ingredient level lower than that of the combined individual 3-isothiazolone and commercial microbicide effective use levels..
Rohm And Haas Company


07/30/15
20150214457 

Thermoelectric material and thermoelectric module


A thermoelectric material is manufactured by a manufacturing process including annealing at an annealing temperature from 125° c. To 200° c.
National Institute Of Advanced Industrial Science And Technology


07/30/15
20150211177 

Press belt in a paper-making machine


A press belt for a shoe-press device for dewatering or smoothing a fibrous web, in particular a paper, cardboard, or tissue web. The press belt has a fiber-reinforced plastic matrix.
Voith Patent Gmbh


07/30/15
20150210889 

Method of applying an organosilane solution to rigid substrates and grout


A stain-treated substrate comprising an extremely thin coating for stain protection. The stain-treated substrate includes substrate material and the extremely thin coating include a molecular layer of organosilane 3-(trimethoxysilyl) propyldimethyl octadecyl ammonium chloride covalently bonded to the surface of the substrate material.

07/30/15
20150210715 

5,5-heteroaromatic anti-infective compounds


The invention provides a series of 5,5-heteroaromatic compounds, syntheses thereof, compositions thereof, and methods of using such compounds and compositions. Various embodiments provide methods of killing and/or inhibiting the growth of m.
University Of Notre Dame Du Lac


07/30/15
20150210707 

Crystals of dispiropyrrolidine derivatives


Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of mdm2 are provided. The present invention provides crystals of (3′r,4′s,5′r)-n-[(3r,6s)-6-carbamoyltetrahydro-2h-pyran-3-yl]-6″-chloro-4′-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2″-oxo-1″,2″-dihydrodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indole]-5′-carboxamide or a salt thereof which inhibits mdm2 and has anti-tumor activity.
Daiichi Sankyo Company, Limited


07/30/15
20150210638 

Preparation of symmetrical and asymmetrical disulphides by reactive distillation of mixtures of disulphides


The process of the invention is particularly suited to the preparation of dimethyl disulphide or diethyl disulphide from a mixture of symmetrical and/or asymmetrical dialkyl disulphides.. .

07/30/15
20150210618 

Energy efficient the extraction of biomolecules from dilute aqueous solution


The present invention relates to the energy efficient and selective extraction of dilute concentrations of biomolecules, e.g., small organic compounds, e.g., one or more c2-c6 alcohols, one or more c3-c5 carboxylic acids, one or more c8-18 fatty alcohols, one or more c1-c18 dicarboxylic acids, one or more furfurals, one or more furans, one or more butanediols, one or more butadienes, and mixtures thereof, from an aqueous solution using liquid phase dimethyl ether (dme).. .
Phasex Corporation


07/30/15
20150210609 

Ionic liquid alkylation of 1-butene to produce 2,5-dimethylhexane


A process for producing dimethylhexanes (dmh) is provided. The dmh can be used to produce p-xylene.
Uop Llc


07/30/15
20150209321 

Treatment of obesity using non-daily administration of 6-o-(4-dimethylaminoethoxy) cinnamoyl fumagillol


The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using non-daily administration of e.g, a metap-2 inhibitor.. .
Zafgen, Inc.


07/30/15
20150209318 

Pharmaceutical compositions containing dimethyl fumarate


Provided herein are compositions containing compounds, or pharmaceutically acceptable salts, that metabolize to monomethyl fumarate with certain pharmacokinetic parameters and methods for treating, prophylaxis, or amelioration of neurodegenerative diseases including multiple sclerosis using such compositions in a subject, wherein if the compositions contain dimethyl fumarate, the total amount of dimethyl fumarate in the compositions ranges from about 43% w/w to about 95% w/w.. .
Biogen Ma Inc.


07/30/15
20150209257 

Hair dye agent comprising aminopyrimidine derivatives


In which r1 is a c1-c4 alkyl group, r2 is a hydrogen atom, a c1-c8 alkyl group, a c2-c6 alkenyl group, a c1-c6 hydroxyalkyl group, a c2-c6 polyhydroxyalkyl group, a c1-c6 alkoxy group, a c1-c6 alkylamino group, a di-c1-c6 alkylamino group, a c1-c6 polyalkoxy group, a c1-c6 alkylamido-(c1-c6) alkyl group, wherein the amide function can be substituted by one or two groups x, or is an aryl group, y is an nh2 or an oh group, at least one coupler component selected from 3-amino-2-methylamino-6-methoxypyridine, 3-amino-6-methylphenol, 3-amino-2-hydroxypyridine, 1,3 -bis-(2,4-diaminophenoxy)propane, 2,7-dihydroxynaphthalene, 2-methylresorcinol, 2,5-dimethylresorcinol, 4-chlororesorcinol, 3-aminophenol, 2-amino-3-hydroxypyridine, 2-chloro-6-methyl-3-aminophenol, 2,6-dihydroxy-3,4-dimethylpyridine, 2-({3-[(2-hydroxyethyl)amino]-4-methoxy-5-methylphenyl}amino)ethanol, 2-({3-[(2-hydroxyethyl)amino]-2-methoxy-5-methylphenyl}amino)ethanol, 1-methoxy-2-amino-4-beta-hydroxy-ethylaminobenzene (lehmann's blue), 2,4-diaminophenoxyethanol, 5-amino-4-chloro-o-cresol, 2,4-dichloro-m-aminophenol, 2,6-dihydroxy-3,4-dimethylpyridine and/or a physiologically compatible salt of these compounds.. .

07/23/15
20150203514 

Methods of forming 4-chloro-2-fluoro-3-substituted-phenylboronic acid pinacol esters and methods of using the same


Methods include formation of 4-chloro-2-fluoro-3-substituted-phenylboronic acid pinacol esters. The method comprises contacting a 1-chloro-3-fluoro-2-substituted benzene with an alkyl lithium to form a lithiated 1-chloro-3-fluoro-2-substituted benzene.
Dow Agrosciences Llc


07/23/15
20150203507 

Method for preparing dialkyloxydianhyrohexitol by etherification of dianhydrohexitol using a light alcohol, in the presence of an acidic catalyst


A method for preparing a dialkyloxydianhyrohexitol (dimethylisosorbide) composition by etherification of dianhydrohexitol (isosorbide). The aim is to achieve a “clean” method that avoids the use of a methylation agent such as dimethyl sulfate or methyl chloride, which generates stoechiometric quantities of salts, or expensive dialkyl-carbonates, wherein only one of the two methyl groups participates in the preparation of mixed isosorbide ethers.
Universite Claude Bernard Lyon 1


07/23/15
20150202171 

Patch


A patch comprising a support layer and an adhesive layer, wherein the adhesive layer comprises diclofenac sodium, dimethyl sulfoxide, and citric acid; a mass ratio between the diclofenac sodium and the citric acid (mass of diclofenac sodium:mass of citric acid) is 1:0.15 to 1:0.45; and a mass ratio between the diclofenac sodium and the dimethyl sulfoxide (mass of diclofenac sodium:mass of dimethyl sulfoxide) is 1:0.75 to 1:3.. .
Hisamitsu Pharaceutical Co., Inc.


07/23/15
20150201615 

Insect repellent surface composition


Embodiments of the invention relate to a pest-control composition comprising at least one active ingredient and at least two other ingredients; wherein the at least one active ingredient is selected from the group consisting of geraniol, nootketone, amyl cinnamaldehyde, catnip, wintergreen, carvacrol, d-limonene, orange oil, lauric acid, alpha pinene, mint, cornmint oil, lemon oil, eucalyptus, eugenol, peppermint, lemongrass oil, and terpenes; and wherein the at least two other ingredients are selected from the group consisting of 2-propanol, alcohol, ethanol, monobutyl ether, ethylene glycol, terpenes, ethoxylated alcohol, dodecanol, ammonia, soap, lauryl polyglucose, polyethylene glycol, sodium lauryl sulfate, sodium olefin sulfonate, cocamidapropyl betaine, alkylbenzene sulfonate, polyoxyethelene alkylphenol sulfate, sodium dodecyl benzene sulfonate, sodium sterate, potassium sterate, potassium myristate, tomadol, polyglyceryl sterate, glycol monosterate, potassium oleate, polyglyceryl oleate, tween, polymers, acrylic polymers, ethyl cellulous, carboxymethyl cellulose, sodium hydroxide, ammonium hydroxide, polyacrylate polymer, polyvinyl pyrolidane, lauric diethanolamine, dimethyldodecylamine oxide, aspartic acid tetrasodium salt, and sodium citrate.. .
Tyratech, Inc.


07/16/15
20150197886 

Grafted para-aramid fiber and making


A method of making a fiber comprised of poly(p-phenylene terephthalamide) having monomer groups grafted onto the fiber surface, the method comprising the steps of (i) providing a fiber of poly(p-phenylene terephthalamide) that has been dried to remove adsorbed moisture, (ii) treating the fiber, in a non-polar solvent that will not dissolve the fiber, with a phosphazene base that exhibits a pka in dimethylsulfoxide of at least 21 so as to generate anions at the amide sites on the surface of the poly(p-phenylene terephthalamide) fiber, (iii) washing the base-activated fiber with an aprotic solvent, (iv) grafting a monomer onto the anion sites so as to introduce reactive functional groups onto the surface of the poly(p-phenylene terephthalamide) fiber, and (v) washing the grafted fiber of step (iv) with a protic solvent to extract any residual base compounds and grafting agents that are unbound to the surface of the fibers.. .
E I Du Pont De Nemours And Company


07/16/15
20150197544 

Compositions comprising enzyme-cleavable oxycodone prodrug


The embodiments provide compound kc-8, n-1-[3-(oxycodone-6-enol-carbonyl-methyl-amino)-2,2-dimethyl-propylamine]-arginine-glycine-malonic acid, or acceptable salts, solvates, and hydrates thereof. The present disclosure also provides compositions, and their methods of use, where the compositions comprise a prodrug, compound kc-8, that provides controlled release of oxycodone.
Signature Therapeutics, Inc.


07/16/15
20150196688 

Glycosaminoglycan and synthetic polymer material for blood-contacting applications


Provided herein is a composite, comprising: a polymer host selected from the group consisting of low-density polyethylene (ldpe), linear low-density polyethylene (lldpe), polyethylene terephthalate (pet), polytetrafluoroethylene (ptfe), and polypropylene (pp), polyurethane, polycaprolactone (pcl), polydimethylsiloxane (pdms), polymethylmethacrylate (pmma), and polyoxymethylene (pom); and a guest molecule comprising hyaluronic acid; wherein the guest molecule is disposed within the polymer host, and wherein the guest molecule is covalently bonded to at least one other guest molecule. Also provided herein are methods for forming the composite, and blood-contracting devices made from the composite, such as heart valves and vascular grafts..
Colorado State University Research Foundation


07/09/15
20150191747 

Microbial fermentation for the production of terpenes


The invention provides a method for producing a terpene or a precursor thereof by microbial fermentation. Typically, the method involves culturing a recombinant bacterium in the presence of a gaseous substrate whereby the bacterium produces a terpene or a precursor thereof, such as mevalonic acid, isopentenyl pyrophosphate, dimethylallyl pyrophosphate, isoprene, geranyl pyrophosphate, farnesyl pyrophosphate, and/or farnesene.
Lanza Tech New Zealand Limited


07/09/15
20150191666 

Process for producing renewable jet fuel compositions


Processes for producing jet fuel are disclosed. In one embodiment, syngas is converted to methanol, and a first portion of the methanol is converted to olefins using a methanol-to-olefins catalyst.

07/09/15
20150191414 

Process for the preparation of fluoroalkyl (alkyl carbonates and carbamates


Fluoroalkyl alkyl carbonates and fluorosubstituted carbamates which are suitable as additives or solvents in lithium ion batteries are prepared from fluoroalkyl fluoroformates and the respective alcohol or amine. Methanol is the preferred alcohol, dimethylamine and diethylamine are preferred amines.
Solvay Fluor Gmbh


07/09/15
20150190336 

Filaggrin gene expression promoter


The present invention provides a novel substance that promotes expression of filaggrin gene involved in improvement of the moisture retention function of skin. The inventors of the present invention found that expression of filaggrin gene fluctuates rhythmically over a roughly 24 hour cycle, screened candidate substances based on the time at which expression reaches a maximum following addition of the candidate substance, and identified zanthoxylum extract, 3-(1′-piperidine)propionic acid, geranium oil, cypress oil, rose oil, galvanum oil, pepper oil, basil oil, methyl-o-toluate, methyl anthranilate and dimethyl anthranilate as filaggrin gene expression promoting agents..
Shiseido Company, Ltd.


07/02/15
20150184001 

Fluoropolymer composition


The invention pertains to a fluoropolymer composition suitable for adhering a fluoropolymer coating onto a surface, in particular onto a metal surface, said composition comprising: at least one fluoropolymer [polymer (a)]; at least one aromatic polycondensation polymer [polymer (p)]; a solvent mixture [mixture (m)] comprising dimethylsulfoxide (dmso) and at least one solvent selected from the group consisting of diesters of formula (ide) and ester-amide of formula (1ea): r1—ooc-ade-coo—r2 (1de), r1—ooc-aea-co—nr3r4 (1ea) wherein: r1 and r2, equal to or different from each other, are independently selected from the group consisting of c1-c20 hydrocarbon groups; r3 and r4, equal to or different from each other, are independently selected from the group consisting of hydrogen, c1-c36 hydrocarbon groups, possibly substituted, being understood that r3 and r4 might be part of a cyclic n moiety including the nitrogen atom to which they are bound, said cyclic moiety being possibly substituted and/or possibly comprising one or more than one additional heteroatom, and mixtures thereof; ade and aea, equal to or different from each other, are independently a linear or branched divalent alkylene group, and to a method for coating a surface, specifically a metal surface, with a fluoropolymer, using said fluoropolymer composition.. .
Solvay Specialty Polymers Italy S.p.a.


07/02/15
20150183920 

Modified polyalkylene oxide


Wherein r2represents methyldiphenylene, hexamethylene, methyldicyclohexylene, 3-methyl-3,5,5-trimethylcyclohexylene, dimethylphenylene, or tolylene.. .

07/02/15
20150182572 

Plant extract and the process for treating hepatic fibrosis and liver cancer


An extract of graptopetalum paraguayense prepared by a method that includes: extracting a graptopetalum paraguayense (gp) starting material with an alcoholic solvent to produce an alcoholic extract and a residue; separating the residue from the alcoholic extract; extracting the residue with an aqueous dimethyl sulfoxide (dmso) solvent to produce a dmso extract; subjecting the dmso extract to ultrafiltration using a filter having a selected molecular weight cutoff; drying a fraction retained by the filter to obtain the extract of graptopetalum paraguayense. Uses of an extract of graptopetalum paraguayense for the treatment or prevention of liver fibrosis, hepatic cirrhosis, liver cancer, recurrence of liver fibrosis after surgery, or recurrence of liver cancer after surgery..
Development Center For Biotechnology


07/02/15
20150182540 

Drospirenone for hormone replacement therapy


A pharmaceutical composition comprising as a first active ingredient an estrogen, such as estradiol or estradiol valerate, in sufficient amounts to treat disorders and symptoms associated with deficient endogenous levels of estrogen in women, and as a second active ingredient 6β,7β;15β;16β-dimethylene-3-oxo-17α-preg-4-ene-21,17-carbolactone (drospirenone, drsp) in sufficient amounts to protect the endometrium from the adverse effects of estrogen is useful for, amongst others, treating peri-menopausal, menopausal and post-menopausal women. This composition may be used for hormone replacement therapy and may be administered as a multi-phased pharmaceutical preparation.
Bayer Intellectual Property Gmbh


06/25/15
20150179959 

Organic metal compound, organic light-emitting device employing the same, and preparing the same


Wherein one of r1 and r2 is hydrogen, and the other is trialkyl silyl group; and l is an acetylacetone ligand, a picolinate ligand, a 2-(imidazol-2-yl) pyridine ligand, a 2-(4,5-dimethyl-imidazol-2-yl)pyridine ligand, a 3-(trifluoromethyl)-5-(pyridine-2-yl)-1,2,4-triazolate ligand, or a 3-(tert-butyl)-5-(pyridine-2-yl)-1,2,4-triazolate ligand.. .

06/25/15
20150179316 

Methods of forming nitrides at low substrate temperatures


Provided are methods of forming nitrides at low substrate temperatures, such as less than 500° c. Or even less than 400° c.
Intermolecular Inc.


06/25/15
20150175873 

Oil recovery process, system, and composition


A system, composition, and process are provided for recovering oil from an oil-bearing formation. An oil recovery formulation comprising a polymer dispersed in a fluid that is at least 75 mol % dimethyl sulfide is introduced into an oil-bearing formation, and oil is produced from the formation..
Shell Oil Company


06/25/15
20150175843 

Multilayer film and molded body


A first multilayer film is a multilayer film which contains a layer a on at least one surface of a base film, in which the layer a has (1) a polycaprolactone segment, (2) a polysiloxane segment and/or a polydimethyl siloxane segment, and (3) a urethane bond, and the layer a has a glass transition temperature of from −30 to 0° c. A second multilayer film contains a layer a on at least one surface of a base film, in which the layer a has a scratch recovery time of 3 seconds or less at a temperature of 10° c.
Toray Industries, Inc.


06/25/15
20150175740 

Processing-friendly dianhydride hardener for epoxy resin systems based on 5,5'-carbonylbis(isobenzofuran-1,3-dione)


The present invention provides a composition comprising 5,5′-carbonylbis(isobenzofuran-1,3-dione), 3,3′,4,4′-benzophenonetetracarboxylic acid and at least one monoanhydride compound selected from the group consisting of methylhexahydroisobenzofuran-1,3-dione, 5-methyl-3a,4,7,7a-tetrahydro-4,7-methanoisobenzofuran-1,3-dione, 5-methyl-3a,4,7,7a-tetrahydroisobenzofuran-1,3-dione, 3-methylfuran-2,5-dione, 3,3,4,4,5,5-hexafluorodihydro-2h-pyran-2,6(3h)-dione and 3,3-dimethyldihydrofuran-2,5-dione. The invention also provides a hardener system for an epoxy resin, said hardener system comprising said composition.
Evonik Industries Ag


06/25/15
20150175738 

Processing-friendly dianhydride hardener for epoxy resin systems based on 5,5'-oxybis(isobenzofuran-1,3-dione)


The present invention provides a composition comprising 5,5′-oxybis(isobenzofuran-1,3-dione), 4,4′-oxybis(ortho-phthalic acid) and at least one monoanhydride compound selected from the group consisting of methylhexahydroisobenzofuran-1,3-dione, 5-methyl-3a,4,7,7a-tetrahydro-4,7-methanoisobenzofuran-1,3-dione, 5-methyl-3 a,4,7,7a-tetrahydroisobenzofuran-1,3-dione, 3-methylfuran-2,5-dione, 3,3,4,4,5,5-hexafluorodihydro-2h-pyran-2,6(3h)-dione, and 3,3-dimethyldihydrofuran-2,5-dione. The invention also provides a hardener system for epoxy resins, said hardener system comprising said composition.
Evonik Industries Ag


06/25/15
20150175512 

Method for starting up a dme synthesis reactor


A method for starting up a dme synthesis reactor in which methanol is converted by dehydration to dimethyl ether on a solid catalyst, wherein the catalyst is heated up with condensing methanol vapor, possibly in several steps. In a final treatment step with superheated methanol vapor, the catalyst is dried and its temperature is raised to the starting temperature of the methanol dehydration..
L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes George


06/25/15
20150175499 

Conversion of methanol to olefins and para-xylene


Methods are provided for conversion of methanol and/or dimethyl ether to aromatics, such as a para-xylene, and olefins, such as ethylene and propylene. The methods can be used in conjunction with molecular sieve (zeolite) catalysts that are prepared for use in conjunction with selected effective conversion conditions.
Exxonmobil Chemical Patents Inc.


06/25/15
20150174567 

Hybrid photocatalyst for wastewater remediation


The hybrid photocatalyst for wastewater remediation is a composite of rhodamine b and biobr. The rhodamine b has a concentration between about 0.1 wt % and about 1 wt % of the overall photocatalyst.
King Fahd University Of Petroleum And Minerals


06/25/15
20150174563 

Bound catalyst for selective conversion of oxygenates to aromatics


A catalyst composition includes a zeolite, a binder, and a group 12 transition metal selected from the group consisting of zn, cd, or a combination thereof, the zeolite having a silicon to aluminum ratio of at least about 10, the catalyst composition comprising about 50 wt % or less of the binder based on a total weight of the catalyst composition, the catalyst composition having a micropore surface area of at least about 340 m2/g, a molar ratio of group 12 transition metal to aluminum of about 0.1 to about 1.3, and at least one of (a) a mesoporosity of greater than about 20 m2/g; (b) a diffusivity for 2,2-dimethylbutane of greater than about 1×10−2 sec−1 when measured at a temperature of about 120° c. And a 2,2-dimethylbutane pressure of about 60 torr (about 8 kpa)..
Exxonmobil Research And Engineering Company


06/25/15
20150174562 

Alumina bound catalyst for selective conversion of oxygenates to aromatics


A catalyst composition comprising a zeolite, an alumina binder, and a group 12 transition metal selected from zn and/or cd, the zeolite having a si/al ratio of at least about 10 and a micropore surface area of at least about 340 m2/g, the catalyst composition comprising about 50 wt % or less of the binder, based on a total weight of the catalyst composition, and having a micropore surface area of at least about 290 m2/g, a molar ratio of group 12 transition metal to aluminum of about 0.1 to about 1.3, and at least one of: a mesoporosity of about 20 m2/g to about 120 m2/g; a diffusivity for 2,2-dimethylbutane of greater than about 1×10−2 sec−1 when measured at a temperature of about 120° c. And a 2,2-dimethylbutane pressure of about 60 torr (8 kpa); and a combined micropore surface area and mesoporosity of at least about 380 m2/g..
Exxonmobil Research And Engineering Company


06/25/15
20150174561 

Catalyst for selective conversion of oxygenates to aromatics


A catalyst composition comprises a self-bound zeolite and a group 12 transition metal selected from the group consisting of zn, cd, or a combination thereof, the zeolite having a silicon to aluminum ratio of at least about 10, the catalyst composition having a micropore surface area of at least about 340 m2/g, a molar ratio of group 12 transition metal to aluminum of about 0.1 to about 1.3, and at least one of: (a) a mesoporosity of greater than about 20 m2/g; (b) a diffusivity for 2,2-dimethylbutane of greater than about 1×10−2 sec−1 when measured at a temperature of about 120° c. And a 2,2-dimethylbutane pressure of about 60 torr (about 8 kpa)..
Exxonmobil Research And Engineering Company


06/25/15
20150174140 

Method for on-demand contraception


The invention relates to a method for on-demand contraception, which method comprises administering a progestogen agent or progesterone receptor modulator, such as 17a-acetoxy-11b-(4-n,n-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) in a woman, within 72 hours before an intercourse or within 120 hours after the intercourse.. .
The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv


06/25/15
20150174135 

Flavanoid compounds and process for preparation thereof


The present invention relates to flavanoid compounds of general formula (x1) wherein: r1 is selected from a group consisting of morpholinyl, n-methyl piperizinyl, piperidinyl and n,n′-dimethylamino groups, and n ranges from 3 to 6, and process for preparation thereof. The present invention relates to the demonstration of anti helicobacter pylori activity and gastric antisecretory activity of semisynthetically designed flavonoid compounds, to be used for the prevention and treatment of gastroduodenal disorders in general and peptic ulcer diseases in particular.
Council Of Scientific & Industrial Research


06/18/15
20150171474 

Lithium-ion secondary battery and electrolyte thereof


The present disclosure provides a lithium-ion secondary battery and an electrolyte thereof. The electrolyte of the lithium-ion secondary battery comprises a lithium salt; a non-aqueous solvent and an additive.
Ningde Amperex Technology Limited


06/18/15
20150171473 

Lithium-ion secondary battery and electrolyte thereof


The present disclosure provides a lithium-ion secondary battery and an electrolyte thereof. The electrolyte comprises a lithium salt; a non-aqueous solvent and an additive comprising a first additive and a second additive, the first additive comprises at least one of vinylene carbonate and vinyl ethylene carbonate, the second additive is 4-methylene-1,3-dioxolan-2-one and its derivatives with a structural formula 1 and/or 4,5-dimethylene-1,3-dioxolan-2-one and its derivatives with a structural formula 2; in the structural formula 1 and the structural formula 2, r1, r2, r3 and r4 each are hydrogen, halogen, c1˜c3 alkyl or halogenated alkyl; a weight percentage of the first additive in the electrolyte is 0.2%˜2.0%, a weight percentage of the second additive in the electrolyte is 0.3%˜4.0%.
Ningde Amperex Technology Limited


06/18/15
20150171288 

Light-emitting device and organic-inorganic hybrid pre-polymer composition comprising phosphor


A solid light-emitting device comprising a light-emitting semiconductor element and a phosphor dispersed in a sealant, in which the phosphor is exited by the light emitted by the semiconductor element to emit a visible light of a wavelength differing from that of the light emitted by the semiconductor element and is a silicate phosphor or a phosphor having a hydroxyl group on its surface, and the sealant is a condensation product of a prepolymer produced by condensation of polydimethyl-siloxane having a silanol group at both ends and an oligomer of an alkoxide of a metal or a semimetal or its derivative.. .
Ube Material Industries, Ltd.


06/18/15
20150166865 

Refrigerant mixtures


Use of a gaseous mixture, selected from the group consisting of:—dimethyl ether in a concentration from 85% to 95% by weight and propylene in a concentration from 5% to 15% by weight, and—dimethyl ether in a concentration from 71% to 85% by weight and propane in a concentration from 15% to 29% by weight as a replacement or alternative refrigerant for r134a and/or for other refrigerants which are replacements or alternatives to r134a containing hfc (hydrofluorocarbons), hfo (hydrofluoro olefins) and hfe (hydrofluoro ethers).. .
Tazzetti S.p.a


06/18/15
20150166752 

Polymeric foam


The present invention relates to composition for the preparation of a polymeric foam with improved thermal properties, to a polymeric foam obtainable therefrom, and to a method for preparing such a polymeric foam each for them comprising (i) an at least essentially amorphous polymer resin and (ii) a nucleating agent. The at least essentially amorphous polymer resin is preferably polystyrene.
Clariant International, Ltd.


06/18/15
20150166519 

Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4] oxadiazol-5-yl]-3-nitrobenzene-1,2-diol


This invention relates to novel polymorphs of (ho)2no2(c6h)—(c2n2o)—(c5n)(ch3)2cl2o, to processes for their preparation, and to pharmaceutical compositions containing said novel polymorphs as active pharmaceutical ingredient.. .
Bial - Portela & Ca., S.a. ("portela")


06/18/15
20150165125 

Lubricant coating and medical injection device comprising such a coating


The invention relates to a lubricant coating (5) for a medical injection device (1), comprising successively: —a bottom layer (50) in contact with the medical device surface (21) of the container to be lubricated, comprising a mixture of cross-linked and non-cross-linked poly-(dimethylsiloxane), —an intermediate layer (51) consisting essentially of oxidized poly-(dimethylsiloxane) and having a thickness comprised between 10 and 30 nm and, —a top layer (52) consisting essentially of non-cross-linked poly-(dimethylsiloxane) and having a thickness of at most 2 nm. The invention also relates to a medical injection device comprising such a lubricant coating, and a manufacturing process for said coating..
Becton Dickinson France


06/18/15
20150164849 

Combination therapy for treatment of multiple sclerosis


The present invention relates to a method of treating ms in a human patient in need of such treatment and comprises administering to said patient a combination therapy in a single oral dosage form (e.g. A tablet or capsule) of dim ethyifurrta rate and one agent selected from teriflunomide (or its prodrug leflunomide), fingolimod and laquinimod.
Forward Pharma A/s


06/11/15
20150159009 

Graft copolymers, their preparation and use in capillary electrophoresis


The invention relates to graft copolymers, their preparation, and compositions, such as electrophoresis separation media, containing the same; also to ultra-high molecular weight poly(n,n-dimethylacrylamide) (“poly(dma)”) polymers, their preparation, and compositions, such as electrophoresis separation media, containing the same; and more particularly to supports, such as capillaries, containing these polymers and methods for separating biomolecules, especially polynucleotides, using capillary electrophoresis. The graft copolymers can be prepared by, e.g., grafting polyacrylamide units onto a poly(dma) backbone.
Applied Biosystems, Llc


06/11/15
20150158893 

Process for preparing malathion for pharmaceutical use


The present invention provides a process for preparing a highly pure form of malathion having a reduced level of toxic impurities. In addition, the malathion prepared by the process of this invention is storage stable.
Taro Pharmaceuticals North America, Inc.


06/11/15
20150158849 

Solid salt forms of a pyrrole substituted 2-indolinone


The present invention relates to solid salt forms of the 3-pyrrole substituted 2-indolinone compound 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3z)-ylidenemethyl]-2,4-dimethyl-1h-pyrrole-3-carboxylic acid (2-pirrolidin-1-yl-ethyl)-amide. It also relates to polymorphs of the phosphate salt of the amide.
Zoetis Llc


06/11/15
20150158798 

Process for producing 4-cyclohexyl-2-methyl-2-butanol


The present invention relates to the field of perfumery. More particularly, it concerns a process for the preparation of 2-methyl-4-phenyl-2-butanol, or even 4-cyclohexyl-2-methyl-2-butanol from 4,4-dimethyl-2,6-diphenyl-1,3-dioxane..
Firmenich Sa


06/11/15
20150158275 

Non-yellowing glass laminate structure


A glass laminate structure comprising an internal glass sheet, an external glass sheet, and at least one polymer interlayer intermediate the external and internal glass sheets where the polymer interlayer includes a phenol, 2-(2h-benzotriazol-2-yl)-4,6-bis(1,1-dimethylpropyl) additive, a 2-(2h-benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol additive, a 2-(2h-benzotriazol-2-yl)-6-(1-methyl-1-phenylethyl)-4-(1,1,3,3-tetramethylbutyl)phenol additive, or an hydroxyphenyl substituted benzotriazole additive without a chlorine substituent. In some embodiments, the external and/or internal glass sheets can be formed from non-chemically strengthened glass, and in other embodiments, the external and/or internal glass sheets can be formed from chemically strengthened glass.
Corning Incorporated


06/11/15
20150157729 

Topical composition comprising a film-forming polymer for delivering an active ingredient to skin


A sprayable film-forming pharmaceutical composition for dermal application comprises at least one therapeutically active ingredient dissolved in a pharmaceutically acceptable propellant selected from the group consisting of dimethyl ether, diethyl ether and methylethylether, and a mixture of dimethyl ether, diethylether and methylethyl ether, and a second propellant selected from c3-5 alkanes, hydrofluoroalkanes, hydrochloroalkanes, fluoroalkanes and chlorofluoroalkanes, the propellant being present in an amount of 50-99.5% w/w of the composition, the composition further comprising a film-forming polymer, a plasticizer and an oily release-enhancing agent.. .
Leo Pharma A/s


06/11/15
20150157640 

Novel compounds


Wherein r1 is 2-indanyl, r2 is 1-methylpropyl, r3 is a group selected from 2,6-dimethyl-3-pyridyl or 4,6-dimethyl-3-pyridyl, r4 represents methyl and r5 represents hydrogen or methyl or, r4 and r5 together with the nitrogen atom to which they are attached represent morpholino and pharmaceutically acceptable derivatives thereof are described, as are processes for their preparation, pharmaceutical compositions containing them and their use in medicine, particularly their use as oxytocin antagonists.. .

06/11/15
20150157046 

Nutritional product composition for the mind


A nutritional product composition for the mind to support mental performance and alertness, promote superior cognitive function, support focus, attention and memory, help with age-related declines in learning, organization and concentration, and help protect a user's brain from free radical damage. The nutritional product composition for the mind includes a synergistic blend of nutrients and a silica gel that increases the rate of metabolism of cells to increase the rate of absorption of the nutrients and increase levels of acetylcholine rapidly.
Lifewave, Inc.




Popular terms: [SEARCH]

Dimethyl topics: Physiologic, Hydrochloric Acid, Fresnel Zone, Aberration, Ophthalmic, Liquid Crystal, Imaging System, Pharmaceutically Acceptable Salt, Pharmaceutically Acceptable Salts, Chloric Acid, Tartaric Acid, Fumaric Acid, Antagonist, Bradykinin, Enantiomer

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Dimethyl for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dimethyl with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.6187

4649

459671 - 0 - 103